1. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
- Author
-
Mak VC, Wong OG, Siu MK, Wong ES, Ng WY, Wong RW, Chan KK, Ngan HY, and Cheung AN
- Subjects
- Animals, Antibodies, Apoptosis, Carcinogenicity Tests, Cell Movement, Choriocarcinoma genetics, Choriocarcinoma metabolism, DNA-Binding Proteins metabolism, Female, Gene Expression Regulation, Neoplastic, Gestational Trophoblastic Disease genetics, Gestational Trophoblastic Disease metabolism, Humans, Hydatidiform Mole genetics, Hydatidiform Mole metabolism, Hydatidiform Mole pathology, Mice, Mice, Inbred BALB C, Mice, Nude, Oncogene Protein v-akt genetics, Phosphatidylinositol 3-Kinases genetics, Placenta metabolism, Pregnancy, Rabbits, Transcription Factors metabolism, Trophoblasts metabolism, Choriocarcinoma pathology, DNA-Binding Proteins genetics, Gestational Trophoblastic Disease pathology, Oncogene Protein v-akt metabolism, Phosphatidylinositol 3-Kinases metabolism, Signal Transduction, Transcription Factors genetics
- Abstract
Human placental trophoblasts can be considered pseudomalignant, with tightly controlled proliferation, apoptosis, and invasiveness. Gestational trophoblastic disease (GTD) represents a family of heterogeneous trophoblastic lesions with aberrant apoptotic and proliferative activities and dysregulation of cell signaling pathways. We characterize the oncogenic effects of factor that binds to the inducer of short transcripts of HIV-1 [FBI-1, alias POZ and Krüppel erythroid myeloid ontogenic factor (POKEMON)/ZBTB7A] in GTD and its role in promoting cell aggressiveness in vitro and tumor growth in vivo. IHC studies showed increased nuclear expression of FBI-1, including hydatidiform moles, choriocarcinoma (CCA), and placental site trophoblastic tumor, in GTD. In JAR and JEG-3 CCA cells, ectopic FBI-1 expression opposed apoptosis through repression of proapoptotic genes (eg, BAK1, FAS, and CASP8). FBI-1 overexpression also promoted Akt activation, as indicated by Akt-pS473 phosphorylation. FBI-1 overexpression promoted mobility and invasiveness of JEG-3 and JAR, but not in the presence of the phosphoinositide 3-kinase inhibitor LY294002. These findings suggest that FBI-1 could promote cell migration and invasion via phosphoinositide 3-kinase/Akt signaling. In vivo, nude mice injected with CCA cells with stable FBI-1 knockdown demonstrated reduced tumor growth compared with that in control groups. These findings suggest that FBI-1 is clinically associated with the progression of, and may be a therapeutic target in, GTD, owing to its diverse oncogenic effects on dysregulated trophoblasts., (Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF